Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel Free SLPE Stock Alerts

Standard Life Private Equity Trust (SLPE) Stock Chart & Stock Price History

Standard Life Private Equity Trust logo
GBX 604 0.00 (0.00%)
As of 05/12/2026
Compare

Standard Life Private Equity Trust Stock Price Performance

The Standard Life Private Equity Trust (SLPE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 5.23%, with a year-to-date return of -1.95%. In the past month, the stock has increased 3.07%, reflecting recent market activity.

As of the latest close, Standard Life Private Equity Trust traded at GBX 604 with a market cap of £928.63 million and volume of 37,023 shares. Five years ago, the stock traded at GBX 458, representing a 31.88% increase over that period. At the time, it had a market cap of £704.16 million and a volume of 502,441 shares.

Receive SLPE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Standard Life Private Equity Trust and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.33%
1 Month
Performance
+3.07%
3 Month
Performance
-2.58%
Year-To-Date
Performance
-1.95%
1 Year
Performance
+5.23%
5 Year
Performance
+31.88%

SLPE Stock Chart for Thursday, May, 14, 2026

SLPE Chart by TradingView

Standard Life Private Equity Trust Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
05/13/2026GBX 602GBX 604
+0.33%		GBX 618GBX 596.1637,023 shs£928.63 million
05/12/2026GBX 606GBX 602
-0.66%		GBX 614GBX 59844,426 shs£925.55 million
05/11/2026GBX 606GBX 606GBX 618GBX 59827,519 shs£931.70 million
05/08/2026GBX 602GBX 606
+0.66%		GBX 618GBX 59827,519 shs£931.70 million
05/07/2026GBX 620GBX 602
-2.90%		GBX 620GBX 600130,118 shs£925.55 million
05/06/2026GBX 620GBX 620GBX 620GBX 59842,436 shs£953.23 million
05/05/2026N/AGBX 620GBX 620GBX 59842,436 shs£953.23 million
04/30/2026GBX 608GBX 602
-0.99%		GBX 605.80GBX 596113,829 shs£925.55 million
04/29/2026GBX 600GBX 608
+1.33%		GBX 610GBX 59493,936 shs£934.78 million
04/28/2026GBX 604GBX 600
-0.66%		GBX 608GBX 590145,092 shs£922.48 million
04/27/2026GBX 604GBX 604GBX 612.72GBX 59494,875 shs£928.63 million
04/24/2026GBX 606GBX 604
-0.33%		GBX 610GBX 599.4861,876 shs£928.63 million
04/23/2026GBX 604GBX 606
+0.33%		GBX 620GBX 60043,473 shs£931.70 million
04/22/2026GBX 610GBX 604
-0.98%		GBX 616GBX 59624,581 shs£928.63 million
04/21/2026GBX 598GBX 610
+2.01%		GBX 610GBX 59251,649 shs£937.85 million
04/20/2026GBX 598GBX 598GBX 618GBX 59068,634 shs£919.40 million
04/17/2026GBX 606GBX 598
-1.32%		GBX 606GBX 596.0979,450 shs£919.40 million
04/16/2026GBX 606GBX 606GBX 612GBX 578133,440 shs£931.70 million
04/15/2026GBX 586GBX 606
+3.41%		GBX 612GBX 578133,440 shs£931.70 million
04/14/2026GBX 570GBX 586
+2.81%		GBX 586GBX 56673,215 shs£900.95 million
04/13/2026GBX 570GBX 570GBX 582GBX 568247,320 shs£876.35 million
Related Companies

This page (LON:SLPE) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners
Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using it...
Market Tactic | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
The Rare Earth Shift Few Saw Coming
Rare earth elements are the hidden backbone of electric vehicles, modern defense technology, and advanced elec...
i2i Marketing Group, LLC | Sponsoredtc pixel
You'll buy SpaceX at $1.75 trillion. Insiders bought at $20 billion.
Insiders bought SpaceX at $20 billion. Banks got in at $100 billion. By the time it hits your brokerage accoun...
Behind the Markets | Sponsoredtc pixel
Peptide Company Lands Exclusive MMA Wellness Partnership
A publicly traded peptide company just signed an exclusive partnership with a NYSE-listed MMA media platform t...
The Tomorrow Investor | Sponsoredtc pixel
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
This is the worst news for stocks in 50 years
Goldman Sachs and Morgan Stanley are issuing a rare warning: what's ahead for U.S. stocks could be the worst e...
TradeSmith | Sponsoredtc pixel